[
  {
    "ts": null,
    "headline": "CAH Stock Up Nearly 7% This Year: Is Now the Time to Buy?",
    "summary": "CAH continues to grow on the back of its robust product portfolio and a strong quarterly result.",
    "url": "https://finnhub.io/api/news?id=05e3d0388003aa09db195fe8326228debe82a860d726ec14bd991d2264d77330",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741633200,
      "headline": "CAH Stock Up Nearly 7% This Year: Is Now the Time to Buy?",
      "id": 133189567,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "CAH continues to grow on the back of its robust product portfolio and a strong quarterly result.",
      "url": "https://finnhub.io/api/news?id=05e3d0388003aa09db195fe8326228debe82a860d726ec14bd991d2264d77330"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health (NYSE:CAH) Welcomes New Independent Directors With Tech and Healthcare Expertise",
    "summary": "Cardinal Health (NYSE:CAH) recently appointed Robert Musslewhite and Sudhakar Ramakrishna to its Board of Directors, which may have reinforced investor confidence, culminating in a 5% share price increase over the last quarter. These appointments enhance the company's governance with expertise from healthcare and cybersecurity sectors. Despite the Dow Jones and other major indices facing declines due to economic concerns and tariff-related uncertainty, Cardinal Health sustained positive...",
    "url": "https://finnhub.io/api/news?id=a4308d0c2a77010e960122784885b02172ccf04dffe6dc45610215b36bad6ae4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741626942,
      "headline": "Cardinal Health (NYSE:CAH) Welcomes New Independent Directors With Tech and Healthcare Expertise",
      "id": 133189568,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health (NYSE:CAH) recently appointed Robert Musslewhite and Sudhakar Ramakrishna to its Board of Directors, which may have reinforced investor confidence, culminating in a 5% share price increase over the last quarter. These appointments enhance the company's governance with expertise from healthcare and cybersecurity sectors. Despite the Dow Jones and other major indices facing declines due to economic concerns and tariff-related uncertainty, Cardinal Health sustained positive...",
      "url": "https://finnhub.io/api/news?id=a4308d0c2a77010e960122784885b02172ccf04dffe6dc45610215b36bad6ae4"
    }
  },
  {
    "ts": null,
    "headline": "Positive Trial Data on Evolut TAVR Likely to Support MDT Stock",
    "summary": "At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.",
    "url": "https://finnhub.io/api/news?id=a53a15a960f0af370bc11d63c9b1dd5fda11443da255593d31b8fa3912707136",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741610280,
      "headline": "Positive Trial Data on Evolut TAVR Likely to Support MDT Stock",
      "id": 133185390,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.",
      "url": "https://finnhub.io/api/news?id=a53a15a960f0af370bc11d63c9b1dd5fda11443da255593d31b8fa3912707136"
    }
  },
  {
    "ts": null,
    "headline": "Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors",
    "summary": "Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025.",
    "url": "https://finnhub.io/api/news?id=fc0dbca8160190ddd66da50a67beebe71f8d49745fe0e20bfe2ee4c69412dee1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741603500,
      "headline": "Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors",
      "id": 133189570,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025.",
      "url": "https://finnhub.io/api/news?id=fc0dbca8160190ddd66da50a67beebe71f8d49745fe0e20bfe2ee4c69412dee1"
    }
  }
]